Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MARS-PD: Meridian Activation Remedy System for Parkinson's Disease - A Single-center, Rater-blinded, Parallel Randomized Controlled Trial

NCT05621772 is registered in ClinicalTrials.gov with Korea Health Industry Development Institute as lead sponsor.

NCT NCT05621772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05621772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MARS-PD: Meridian Activation Remedy System for Parkinson's Disease - A Single-center, Rater-blinded, Parallel Randomized Controlled Trial
Lead sponsor
Korea Health Industry Development Institute
Phase
Not applicable
Overall status
Completed
Start date
April 8, 2022
Completion date
July 31, 2025
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease